Frontiers in surgery · 2025
Early results from the use of an innovative vertical fascial traction system for the management of patients with open abdomen.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ioannidis Orestis, Brenta Aliki, Theodorou Alexis, Siozos Konstantinos, Gemousakakis Georgios, Anestiadou Εlissavet, Klonou Ekaterini, Symeonidis Savvas Konstantinos, Bitsianis Stefanos, Kotidis Efstathios, Mantzoros Ioannis, Pramateftakis Manousos Georgios, Angelopoulos Stamatios
Аннотация
BACKGROUND: The combination of negative pressure wound therapy (NPWT) with dynamic fascial traction is currently considered the preferred method for temporary closure of the open abdomen (OA). However, this approach often requires repeated returns to the operating room for further fascial approximation. The aim of this study was to present our institution's experience with a vertical fascial traction device (VTD) for OA management and early closure.
METHODS: This is a prospective registry of patients treated with the VTD between May 2023 and the present. The system used is commercially named Fasciotens® Abdomen, manufactured by Fasciotens GmbH (Essen, Germany).
RESULTS: Definitive abdominal closure was achieved in 11 of 13 patients. Eight patients underwent primary midline suture, while 3 patients-all with pre-existing hernias-required mesh reinforcement. Two patients died before closure could be performed.
CONCLUSIONS: The vertical fascial traction device applies continuous upward traction to the rectus abdominis fascia through an external frame anchored to the pelvis and thorax, thereby increasing abdominal compartment volume and reducing intra-abdominal pressure. This innovative technique facilitates earlier and safer abdominal wall closure and represents a promising adjunct in the management of the open abdomen.
METHODS: This is a prospective registry of patients treated with the VTD between May 2023 and the present. The system used is commercially named Fasciotens® Abdomen, manufactured by Fasciotens GmbH (Essen, Germany).
RESULTS: Definitive abdominal closure was achieved in 11 of 13 patients. Eight patients underwent primary midline suture, while 3 patients-all with pre-existing hernias-required mesh reinforcement. Two patients died before closure could be performed.
CONCLUSIONS: The vertical fascial traction device applies continuous upward traction to the rectus abdominis fascia through an external frame anchored to the pelvis and thorax, thereby increasing abdominal compartment volume and reducing intra-abdominal pressure. This innovative technique facilitates earlier and safer abdominal wall closure and represents a promising adjunct in the management of the open abdomen.